Please assess the completion status of the following clinical trial:

Trial Title: Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Fulfill the diagnostic criteria for major depression according to the Diagnostic and Statistical Manual of Mental Disorders (most recent edition)~* Failure to respond to at least 2 adequate drug therapies for the current depression episode~* MADRS score of 20 or above (moderate - severe~* ASA physical status classification I to III~Exclusion Criteria:~* Inability to obtain informed consent~* ASA physical status classification IV~* Complication by any serious physical diseases such as cardiovascular disease (including untreated HTN), respiratory disease, cerebrovascular disease, intracranial HTN (including glaucoma), or seizures~* Presence of foreign body (including pacemaker)~* Pregnancy~* Allergies to anesthetics used in study Includes: a) Ketamine b) Propofol c) Eggs d) Egg products e) Soybeans f) Soy products

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Propofol (Type: ACTIVE_COMPARATOR): The control group will receive propofol 1 mg/kg and remifentanil 1 mcg/kg intravenously
- Ketamine (Type: EXPERIMENTAL): Study group will receive ketamine 0.75 mg/kg and remifentanil 1 mcg/kg intravenously

Based on this trial design, predict the completion outcome and termination type (if applicable).